Observational study finds higher waist fat associated with increased heart failure risk — Evidence Review
Published by researchers at National Yang Ming Chiao Tung University, Taipei Veterans General Hospital
Researched by
— the AI search engine for science
Table of Contents
New research suggests that waist fat, rather than overall body weight, is a stronger predictor of heart failure risk, with inflammation likely mediating this effect. Related studies largely agree, indicating that where fat is stored—especially around the abdomen—matters more for cardiovascular outcomes than body mass index (BMI) alone, as reported by researchers from National Yang Ming Chiao Tung University.
- Multiple large-scale meta-analyses and observational studies support the finding that abdominal or visceral adiposity, measured via waist circumference or waist-to-height ratio, more strongly predicts heart failure and cardiovascular events than BMI, even among those with “normal” weight 1 2 5.
- Evidence from diverse cohorts indicates that individuals with normal BMI but high body fat or central adiposity (“normal weight obesity” or “lean-fat” phenotype) face elevated cardiovascular and heart failure risks, reinforcing the importance of fat distribution over weight alone 5 6.
- Inflammation is consistently identified as a mechanistic link between central adiposity and cardiovascular risk, with studies showing that higher inflammation markers are associated with adverse outcomes independent of traditional risk factors 4 8.
Study Overview and Key Findings
Heart failure rates continue to rise globally, and conventional screening tools often rely on BMI to assess risk. However, recent attention has turned to “normal weight” individuals who still experience adverse cardiovascular outcomes. This study addresses a timely gap by examining how central adiposity (belly fat) and systemic inflammation relate to heart failure risk in a high-risk, predominantly African American cohort—a population historically underrepresented in cardiovascular research. Importantly, the study investigates whether measuring waist circumference or waist-to-height ratio can improve early identification of individuals at risk, potentially guiding more effective prevention strategies.
| Property | Value |
|---|---|
| Organization | National Yang Ming Chiao Tung University, Taipei Veterans General Hospital |
| Authors | Szu-Han Chen, Sadiya S. Khan |
| Population | African American adults |
| Sample Size | n=1998 |
| Methods | Observational Study |
| Outcome | Heart failure risk, waist circumference, inflammation levels |
| Results | Higher waist fat linked to increased heart failure risk, not BMI. |
The study, presented at the American Heart Association's EPI|Lifestyle Scientific Sessions, followed 1,998 African American adults from Jackson, Mississippi, for a median of nearly seven years. None had heart failure at enrollment. Researchers measured various fat indices (weight, BMI, waist circumference, waist-to-height ratio) and inflammation markers (high-sensitivity C-reactive protein).
Key findings:
- 112 participants developed heart failure during follow-up.
- Greater waist circumference and waist-to-height ratio, but not higher BMI, were linked to increased heart failure risk.
- Elevated inflammation levels were associated with higher heart failure incidence.
- Inflammation explained about 25–33% of the relationship between abdominal fat and heart failure.
The study suggests that screening for central adiposity and inflammation could offer earlier and more accurate identification of individuals at risk, beyond what BMI alone can provide.
Literature Review: Related Studies
To contextualize these findings, we searched the Consensus paper database (over 200 million research papers) using the following queries:
Summary Table
| Topic | Key Findings |
|---|---|
| How does central (abdominal) fat affect heart failure risk? | - Abdominal or visceral fat is more strongly associated with heart failure incidence and mortality than BMI alone 1 2 5. - Individuals with high waist-to-hip or waist-to-height ratio are at increased risk for adverse cardiovascular outcomes, even when BMI is normal 5 6. |
| Is BMI a reliable predictor of cardiovascular and heart failure risk? | - BMI has a J-shaped relationship with mortality, but does not reliably account for fat distribution, leading to missed risk in some "normal weight" individuals 11 12 13. - Studies show that individuals with normal BMI but high body fat ("normal weight obesity") are at increased risk of cardiometabolic dysregulation and cardiovascular mortality 6 15. |
| What roles do inflammation and metabolic health play in risk? | - Inflammation markers (e.g., C-reactive protein) are elevated in those with high central adiposity and are linked to higher risk of heart failure and mortality 4 8. - "Metabolically healthy" obese individuals still have higher risk of cardiovascular disease compared to metabolically healthy normal-weight peers, highlighting the importance of metabolic health status 9 10. |
| Are there population differences (e.g., by sex, ethnicity, region)? | - The "obesity paradox" (better outcomes in overweight/obese heart failure patients) is more apparent with BMI than with central fat measures and may be less relevant in Asian and female populations 3 4 5. - Asian and African American populations may have higher risk at lower BMI or with central fat, suggesting ethnicity-specific risk assessment is needed 5 6. |
How does central (abdominal) fat affect heart failure risk?
Several large studies and meta-analyses consistently report that abdominal fat—measured by waist circumference, waist-to-hip ratio, or visceral adipose tissue on imaging—is more predictive of heart failure and cardiovascular outcomes than BMI. The new study's findings align with this evidence, emphasizing that central adiposity poses a significant, independent risk for heart failure even in individuals whose BMI is considered normal.
- Abdominal adiposity, rather than general adiposity (BMI), shows a stronger and more consistent relationship with heart failure incidence and mortality 1 2 5.
- Elevated waist-to-height and waist-to-hip ratios are associated with increased risk of hospitalization and adverse outcomes in both heart failure with preserved and reduced ejection fraction 2 3 4 5.
- Individuals with low BMI but high waist circumference (“lean-fat” phenotype) are at particularly high risk 5.
- These findings suggest that clinical assessments should incorporate measures of central fat, not just BMI 1 2.
Is BMI a reliable predictor of cardiovascular and heart failure risk?
BMI, while widely used, has limitations in predicting individual cardiovascular risk, especially for those with atypical fat distribution. The literature supports the new study's conclusion that BMI alone can be misleading, and that direct measures of central or total body fat are more informative.
- Large meta-analyses confirm a J-shaped association between BMI and mortality, but the nadir (lowest risk) is not always at “normal” BMI, and risk increases both at low and high extremes 11 12 13.
- Normal weight obesity—normal BMI but high body fat—carries substantial risk for metabolic syndrome and cardiovascular mortality, especially in women 6 15.
- Studies highlight that BMI fails to distinguish between fat and lean mass, and does not capture the risk associated with visceral or ectopic fat 15.
- Use of alternative indices (e.g., waist-to-height ratio) improves risk prediction in heart failure patients 3 4 5.
What roles do inflammation and metabolic health play in risk?
Inflammation is increasingly recognized as a mediator between adiposity and cardiovascular disease. The new study’s finding that inflammation explains a significant portion of the link between waist fat and heart failure is consistent with this body of work.
- Higher waist-to-hip ratio and central adiposity are linked to elevated inflammatory markers, which, in turn, are associated with worse heart failure outcomes—especially in women 4 8.
- Metabolically “healthy” obese individuals still display higher rates of heart failure than metabolically healthy, normal-weight peers, indicating that metabolic health status modifies risk but does not negate it 9 10.
- Systemic inflammation may explain why some individuals develop heart failure despite a “healthy” BMI 8.
- The association between abdominal fat, inflammation, and heart disease is seen across diverse populations 4 8 9.
Are there population differences (e.g., by sex, ethnicity, region)?
The relationship between adiposity, fat distribution, and cardiovascular risk varies by sex, ethnicity, and region. The new study, focusing on African American adults, adds to a growing literature demonstrating that risk assessment tools may need to be tailored for specific populations.
- The “obesity paradox” (better survival among overweight/obese individuals with heart failure) is more pronounced with BMI and less so with central adiposity measures; this paradox diminishes or disappears when waist or fat measures are considered 3 4 5.
- Asian patients with heart failure often exhibit the worst outcomes when they are “lean-fat” (normal BMI, high waist-to-height ratio), highlighting ethnic differences in fat distribution and risk 5.
- Sex-specific analyses indicate that women with higher waist-to-hip ratios have higher mortality risk, with inflammation playing a larger pathophysiological role 4 6.
- These differences underscore the importance of population-specific strategies for risk screening and prevention 5 6.
Future Research Questions
Although evidence increasingly points to the importance of central adiposity and inflammation in heart failure risk, several areas remain unclear. Future research is needed to clarify the mechanisms linking visceral fat and inflammation to specific types of heart failure, to evaluate the efficacy of interventions targeting central fat, and to refine risk prediction models for diverse populations.
| Research Question | Relevance |
|---|---|
| Does reducing waist circumference or visceral fat lower heart failure risk? | Interventional studies are needed to determine if targeted weight loss or fat redistribution reduces heart failure incidence, as most current evidence is observational 1 2 8. |
| How does central adiposity affect different types of heart failure (HFpEF vs HFrEF)? | Existing research suggests stronger links with heart failure with preserved ejection fraction, but mechanisms and clinical implications for both subtypes need clarification 2 3 5. |
| What are the best screening tools for early identification of high-risk individuals with normal BMI? | Identifying at-risk individuals with normal BMI but excess central adiposity (“normal weight obesity”) could improve prevention, but optimal practical screening tools are not yet established 5 6 15. |
| What is the role of systemic inflammation in mediating heart failure risk from abdominal fat? | Clarifying the pathways linking inflammation, visceral adiposity, and heart failure could inform targeted therapies and risk stratification 4 8 9. |
| How do risk factors and outcomes vary by race, sex, and age when using waist circumference vs BMI? | Population differences are evident in risk profiles and outcomes, but more research is needed to develop tailored screening and prevention strategies for diverse groups 4 5 6. |
In summary, the growing body of evidence—including this recent study in African American adults—suggests that waist fat and inflammation are more informative than BMI for predicting heart failure risk. Integrating measures of central adiposity and metabolic health into clinical practice could improve early detection and prevention, but further research is needed to refine these approaches and determine their impact on outcomes across diverse populations.